We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$2.33M
Cap. Flow
+$4.29M
Cap. Flow %
0.36%
Top 10 Hldgs %
24.05%
Holding
357
New
34
Increased
28
Reduced
196
Closed
83

Top Buys

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$39.5M
2
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$36.7M
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$32.4M
4
PFE icon
Pfizer
PFE
+$19.3M
5
GL icon
Globe Life
GL
+$10M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$16.6M
2
BNTX icon
BioNTech
BNTX
+$11.4M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$11M
4
LHCG
LHC Group LLC
LHCG
+$10.5M
5
RSG icon
Republic Services
RSG
+$5.74M

Sector Composition

Rank Sector Weight
1 Healthcare 41.98%
2 Financials 15.26%
3 Consumer Discretionary 12.3%
4 Technology 7.74%
5 Industrials 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARE icon
76
Alexandria Real Estate Equities
ARE
$8.27B
$3.48M 0.3%
24,826
+952
+4% +$146K
ANSS
77
DELISTED
Ansys
ANSS
$3.46M 0.29%
15,589
-163
-1% -$41.7K
NTRA icon
78
Natera
NTRA
$45.5B
$3.44M 0.29%
78,451
-13,498
-15% -$643K
MU icon
79
Micron Technology
MU
$1.03T
$3.44M 0.29%
68,595
+24,873
+57% +$1.44M
NTLA icon
80
Intellia Therapeutics
NTLA
$1.69B
$3.41M 0.29%
61,004
-4,312
-7% -$267K
KO icon
81
Coca-Cola
KO
$373B
$3.39M 0.29%
60,557
+2,111
+4% +$131K
SGMO
82
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.34M 0.28%
682,300
-96,469
-12% -$496K
YUMC icon
83
Yum China
YUMC
$16.4B
$3.33M 0.28%
+70,393
New +$3.38M
PEP icon
84
PepsiCo
PEP
$189B
$3.22M 0.27%
19,706
-1,126
-5% -$194K
NVDA icon
85
NVIDIA
NVDA
$5.43T
$3.21M 0.27%
264,140
-22,760
-8% -$360K
CCK icon
86
Crown Holdings
CCK
$13.1B
$3.2M 0.27%
39,447
-5,578
-12% -$520K
ADBE icon
87
Adobe
ADBE
$103B
$3.19M 0.27%
11,596
+1,200
+12% +$454K
IOVA icon
88
Iovance Biotherapeutics
IOVA
$3.05B
$3.14M 0.27%
327,926
-84,162
-20% -$971K
PG icon
89
Procter & Gamble
PG
$335B
$3.12M 0.26%
24,725
-271
-1% -$38.5K
CPRT icon
90
Copart
CPRT
$26.8B
$3.07M 0.26%
115,560
-64,260
-36% -$1.91M
SFM icon
91
Sprouts Farmers Market
SFM
$8.03B
$3.04M 0.26%
+109,462
New +$3.11M
GDRX icon
92
GoodRx Holdings
GDRX
$1.22B
$3.01M 0.26%
645,086
-362,849
-36% -$2.29M
KURA icon
93
Kura Oncology
KURA
$882M
$2.98M 0.25%
218,366
-15,907
-7% -$245K
EDIT icon
94
Editas Medicine
EDIT
$436M
$2.96M 0.25%
242,248
-17,584
-7% -$274K
TDOC icon
95
Teladoc Health
TDOC
$1.22B
$2.83M 0.24%
111,820
-12,445
-10% -$437K
HTHT icon
96
Huazhu Hotels Group
HTHT
$12.7B
$2.8M 0.24%
83,400
-76,428
-48% -$2.89M
ALLO icon
97
Allogene Therapeutics
ALLO
$714M
$2.79M 0.24%
258,214
-47,039
-15% -$639K
EXAS
98
DELISTED
Exact Sciences
EXAS
$2.71M 0.23%
83,468
-32,992
-28% -$1.36M
FATE icon
99
Fate Therapeutics
FATE
$317M
$2.7M 0.23%
120,479
-8,734
-7% -$252K
ITUB icon
100
Itaú Unibanco
ITUB
$81.6B
$2.64M 0.22%
579,303
-383,747
-40% -$1.64M
2 3
4
5 6

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q3 2022 Portfolio in Review

As of Q3 2022, Lombard Odier Asset Management (Switzerland) held 357 positions worth $1.18B, down 0.2% from $1.18B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lombard Odier Asset Management (Switzerland)'s Q3 2022 filing shows 34 new, 28 increased, 196 reduced and 83 closed positions. Its largest new stake was iShares Russell 1000 Value ETF: 263,100 shares worth $35.8M. The largest sale was Visa, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 47% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Lombard Odier Asset Management (Switzerland)'s largest Q3 2022 buy was iShares Russell 1000 Value ETF: 263,100 shares worth $35.8M.
  • Lombard Odier Asset Management (Switzerland) added most to Pfizer in Q3 2022, an estimated $19.3M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q3 2022 reduction was Visa, cutting an estimated $16.6M.
  • Lombard Odier Asset Management (Switzerland) fully exited Signature Bank in Q3 2022, selling an estimated $2.18M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 24% of its $1.18B portfolio in Q3 2022.
  • Lombard Odier Asset Management (Switzerland) opened 34 new positions and closed 83 in Q3 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 0.2% quarter-over-quarter to $1.18B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.